| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.1M | +247.7% |
| SG&A Expense | $7.3M | +99.1% |
| Operating Income | -$23.4M | -182.0% |
| Interest Expense | $282K | -32.2% |
| Net Income | -$18.1M | -84.5% |
| EPS (Basic) | -$2.41 | -42.6% |
| EPS (Diluted) | -$2.41 | -42.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | -65.3% |
| Short-term Investments | $31K | -6.7% |
| Current Assets | $6.9M | -61.0% |
| Total Assets | $6.9M | -61.0% |
| Current Liabilities | $6.4M | +590.3% |
| Long-term Debt | $3.9M | +0.0% |
| Total Liabilities | $8.3M | -31.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.0M | -83.1% |
| Capital Expenditures | $2K | -67.2% |
| Investing Cash Flow | -$2K | -102.1% |
| Financing Cash Flow | $6.5M | -74.6% |
| Free Cash Flow | -$17.0M | -83.0% |
| Stockholders' Equity |
| -$1.3M |
| -123.8% |